PGI17 ARTIFICIAL LIVER SUPPORT SYSTEMS—A MEDICAL AND HEALTH ECONOMIC HTA-REPORT (original) (raw)
Economic evaluation of alternative strategies for the management of patients with heartburn predominant GERD symptoms in Canada
Sameer Rajbhandary
View PDFchevron_right
An algorithm for diagnosis and treatment of refractory GERD
Ronnie Fass
Best Practice & Research Clinical Gastroenterology, 2010
View PDFchevron_right
Cost Analysis of Long-Term Treatment of Patients with Symptomatic Gastroesophageal Reflux Disease (GERD) with Esomeprazole On-Demand Treatment or Esomeprazole Continuous Treatment: An Open, Randomized, Multicenter Study in Switzerland*
T. Szucs
Value in Health, 2009
View PDFchevron_right
Prevalence, Causes, Risk Factors and Updates of Management of GERD
salem alsalem
2020
View PDFchevron_right
New Options for the Management of GERD
Brian Louie
Current Surgery Reports, 2014
View PDFchevron_right
Outpatient Experience of Patients with GERD in the United States: Analysis of the 1998–2001 National Ambulatory Medical Care Survey
Sandra Joshua-gotlib
Digestive Diseases and Sciences, 2005
View PDFchevron_right
Evaluation of the GERD Impact Scale, an international, validated patient questionnaire, in daily practice. Results of the ALEGRIA study
G. Vandenhoven
Acta gastro-enterologica Belgica
View PDFchevron_right
GERD-Related Health Care Utilization, Therapy, and Reasons for Transfer of GERD Patients Between Primary Care Providers and Gastroenterologists in a US Managed Care Setting
Omar Dabbous
Digestive Diseases and Sciences, 2010
View PDFchevron_right
Long-term outcome of medical andsurgical therapies for gerd: Effects on survival
Francisco Ramirez
2000
View PDFchevron_right
A cost-effectiveness analysis of prescribing strategies in the management of gastroesophageal reflux disease
George Triadafilopoulos
The American Journal of Gastroenterology, 2000
View PDFchevron_right
PGI1 COMORBIDITIES DURING THE YEAR FOLLOWING DIAGNOSIS FOR PERSONS WITH AND WITHOUT GERD USING THE AGENCY FOR HEALTH RESEARCH AND QUALITY (AHRQ) 261 SPECIFIC CATEGORIES
Richard A Brook
Value in Health, 2007
View PDFchevron_right
Economic evaluation of alternative strategies for the management of patients with heartburn predominant gastroesophageal reflux disease symptoms in Canada
Sameer Rajbhandary
2007
View PDFchevron_right
Evaluation of GERD Diagnosis, Management, and Outcomes
Rayan Alghamdi
2018
View PDFchevron_right
The Rationality of Drug Use in GERD Patients at The Outpatient Installation of RSUD Dr. Soedarso Pontianak
Nurul Aisiyah
Jurnal Kesehatan
View PDFchevron_right
Outcome of medical and surgical therapy of GERD: Predictive role of quality of life scores and instrumental evaluation
Bruno Amato
International Journal of Surgery, 2014
View PDFchevron_right
Long-term outcome of medical and surgical therapies for GERD: Effects on GERD symptoms and signs
Francisco Ramirez
Gastroenterology, 2000
View PDFchevron_right
Cost-minimization analysis of treatment of gastroesophageal reflux disease
Ismo Linnosmaa
European Journal of Pharmaceutical Sciences, 2004
View PDFchevron_right
Clinical practice pattern of gastroenterologists, primary care physicians, and otolaryngologists for the management of GERD in the Asia-Pacific region: The FAST survey
Paul Lim
Journal of Gastroenterology and Hepatology, 2004
View PDFchevron_right
Randomised clinical trial: a comparison between a GerdQ-based algorithm and an endoscopy-based approach for the diagnosis and initial treatment of GERD
Bjørn Moum
Alimentary Pharmacology & Therapeutics, 2012
View PDFchevron_right
Accounting for the effect of GERD symptoms on patients' health-related quality of life: supporting optimal disease management by primary care physicians
Ingela Wiklund
International Journal of Clinical Practice
View PDFchevron_right
Cost and burden of gastroesophageal reflux disease among patients with persistent symptoms despite proton pump inhibitor therapy: an observational study in France
Magnus Ruth
BMC Gastroenterology, 2013
View PDFchevron_right
Specific count model for investing the related factors of cost of GERD and functional dyspepsia
Azadeh Safaee
Gastroenterology and hepatology from bed to bench, 2013
View PDFchevron_right
A cost analysis of outpatient care for patients with Barrett's esophagus in a managed care setting
Rick Homan
The American Journal of Gastroenterology, 1999
View PDFchevron_right
Precision GERD management for the 21st century
George Triadafilopoulos
Diseases of The Esophagus, 2017
View PDFchevron_right
SYNOPSIS 2016 GERD
radhika agarwal
View PDFchevron_right
Cost-of-disease analysis in patients with gastro-oesophageal reflux disease and Barrett's mucosa
Michael Kulig
Alimentary Pharmacology and Therapeutics, 2006
View PDFchevron_right
The Stretta procedure for the treatment of GERD: 6 and 12 month follow-up of the U.S. open label trial
Paul Anderson
Gastrointestinal Endoscopy, 2002
View PDFchevron_right
Clinical Profile of patients with GERD attending Tertiary care hospital
sabayya bhovi
International Journal of Surgery Science, 2019
View PDFchevron_right
Health-Related quality-of-life and quality-days incrementally gained in symptomatic nonerosive GERD patients treated with lansoprazole or ranitidine
Susan Mathias
Digestive diseases and sciences, 2001
View PDFchevron_right
Caregiver Burden in Gastroparesis and GERD: Correlation with Disease Severity, Healthcare Utilization and Work Productivity
Mohammed Shakhatreh
Digestive Diseases and Sciences, 2019
View PDFchevron_right
The Overlap Between GERD and Functional Bowel Disorders - When East Meets Rome
Ronnie Fass
Journal of Neurogastroenterology and Motility, 2010
View PDFchevron_right
The development of the GERD-HRQL symptom severity instrument
Vic Velanovich
Diseases of the Esophagus, 2007
View PDFchevron_right
GERD 2003 – A Consensus on the Way Ahead
Steven Moss
Digestion, 2003
View PDFchevron_right
Maintenance Treatment for GERD: Residual Symptoms Are Associated with Psychological Distress
Alike Van Der Velden
Digestion, 2008
View PDFchevron_right